Abstract
According to the World Health Organization lung cancer has a high mortality rate causing >1.5 million deaths per year. Efforts have been made to identify molecular markers associated to the development and progression of non-small cell lung carcinoma (NSCLS), which corresponds to ~85% of lung cancer cases, with the aim to discover new therapeutic targets. Among these targets, telomeres ha…